Mahajan, K., & Gaur, N. (2020). Letter in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.). Diabetes Metab Syndr.
Chicago Style aipamenaMahajan, Kunal, and Naresh Gaur. "Letter in Response to the Article: Comorbidities in COVID-19: Outcomes in Hypertensive Cohort and Controversies With Renin Angiotensin System Blockers (Singh Et al.)." Diabetes Metab Syndr 2020.
MLA aipamenaMahajan, Kunal, and Naresh Gaur. "Letter in Response to the Article: Comorbidities in COVID-19: Outcomes in Hypertensive Cohort and Controversies With Renin Angiotensin System Blockers (Singh Et al.)." Diabetes Metab Syndr 2020.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.